A second data stream between formal assessments.
Your endpoints are measured at site visits, which are expensive, episodic, and scheduled around operational reality rather than around the biology. Between visits, the participant is unobserved.
Voice is the cheapest longitudinal instrument available. A participant can produce a usable sample from a phone in under a minute, at whatever cadence your protocol needs, without travelling anywhere. What has been missing is a model trained on enough labelled clinical audio for the resulting signal to be worth analysing.
Two paths. The existing signal library, applied to your cohort at whatever cadence you set — useful where an established sign maps onto your question.
Or custom inference, where we fine-tune the base model on your voice data toward a signal you define. New endpoints, new populations, indications with no existing acoustic literature. You get a dedicated endpoint. Model weights stay with us.
Decentralised collection, site-based collection, or both. Sample capture works from a standard phone.
Grant-funded and government research programmes are served through the same path. We have existing familiarity with the contracting structures.
A new custom signal is not a validated endpoint on day one. It is a hypothesis with a model behind it, and establishing validity is the work your programme exists to do. We are explicit about this at scoping because the alternative is a difficult conversation later.
We do not run your analysis, own your data, or take authorship positions by default.
See it against your own workflow.
We'll walk through what applies in research & life sciences, what doesn't, and where the limits sit, before any commitment.
request a walkthroughAmplifier's voice analysis is not FDA approved and is not a diagnostic device. Narrative interpretations are provided to qualified care or research staff only, never as automated alerts and never directly to the person analyzed.
next: Consumer & Wellness →